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FOREFRONTS IN NEPHROLOGY
NEWS IN ALDOSTERONE ACTION
Introduction
The mineralocorticoid hormone aldosterone was iden- knowledge the generous financial support by the “Fon-
dation Searle pour la recherche sur l’hypertension ettified as the most potent sodium-retaining factor in mam-
les maladies cardiovasculaires.” The best reward for themals in 1952 by Simpson and Tait. Ever since, the ques-
organizers was to observe the very active interactionstion of how this steroid hormone exerts this physiological
between participants and to hear the strong claim for aaction has remained a fascinating area of research. With
second meeting on News in Aldosterone Action to bethe emergence of molecular biology leading to the identi-
organized within two or three years.fication of genes encoding major components of the aldo-
This Kidney International Symposium contains contri-sterone-regulated sodium reabsorptive pathways, such as
butions from each of the 25 Forefronts speakers and byaldosterone synthase, mineralocorticoid receptor (MR),
two of the four lecturers. Thus, it covers most of the11b-hydroxysteroid dehydrogenase type 2 (11b-HSD2)
topics covered during the meeting, in the sequence ofand epithelial Na1 channel (ENaC), new avenues have
their presentation. In addition to the talks delivered byopened for the study of mineralocorticoid action. The
invited speakers, remarkable contributions were madefact that defects in the four genes mentioned above all
by other participants in the form of 22 oral presentationslead to known human genetic diseases affecting blood
and 30 posters. We would like to thank these partici-pressure levels underlines the physiological and clinical
pants, since a large part of the success of the meeting canimportance of this pathway.
be attributed to them. What follows is a brief summary ofAldosterone thus lies at the center of a broad spectrum
the topics of the meeting in this Symposium issue.of research that ranges from molecular, cellular and func-
The first section is devoted to “nuclear receptors,” thetional studies on mineralocorticoid receptor (MR), min-
family of ligand-activated receptors to which the classicaleralocorticoid selectivity and aldosterone-regulated gene
aldosterone receptor called mineralocorticoid receptorproducts, to studies on the functional targets of aldoste-
(MR) and the glucocorticoid receptor (GR) belong.rone action, for example, the epithelial Na1 channel
Pierre Chambon, from Strasbourg, gave an introductoryENaC and the Na,K-ATPase, and their roles in hyper-
lecture in which he emphasized the role played by mole-tension. Furthermore, mineralocorticoid effects in non-
cules that interact with agonist-liganded receptors andclassical target tissues such as brain, vessels, heart and
mediate their action at the level of target genes [tran-skin also emerge as (patho)physiologically important ele-
scription intermediary factors (TIFs) 5 co-activators, co-ments of aldosterone action.
repressors]. An important concept is that some of theseThe aim of the meeting held in Chantilly near Paris
co-activators and co-repressors directly and/or indirectlyin August 1999 was to bring together researchers work-
act on the chromatin structure and thus can confer theing in these different and complementary areas. The
role of molecular switches to nuclear receptors. Givenexchange between them is of particular importance, and
the central role played by nuclear receptors throughoutintegration of the knowledge at these different levels
development and adult life, in many cases in vivo study ofshould lead to novel (patho)physiological views and
their functional role requires that site- and time-specifichence to new therapeutic strategies.
somatic mutagenesis be performed. This presentationWe want to warmly thank the International Society
underlined the need of using adequate new experimentalof Nephrology, which made the organization of this Fore-
systems to address physiologically relevant questions infronts in Nephrology meeting possible. Over 100 partici-
the context of differentiated tissues of the organism. Thepants from 13 countries (Argentina, Australia, Denmark,
other presentations, which related to nuclear receptors,France, Germany, India, Ireland, Israel, Japan, Nether-
treated the following aspects: molecular chaperones arelands, United Kingdom, USA, and Switzerland) at-
shown to play a role in modulating corticosteroid recep-tended the meeting, and among them were many young
tor function. In particular, these receptor-associated pro-scientists who were supported by grants. We also ac-
teins are shown to participate in receptor targeting to
the nucleus and to modulate transactivation specificity.
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molecules is presented. This structural model could repre- remarkable that aldosterone not only acts via nuclear
receptors in such “non-classical” target tissues, but thatsent an important tool for the design of new aldosterone
there are also local sites of its production (in the heartantagonists. Finally, MR and GR are shown to have dif-
and blood vessels), suggesting that aldosterone mightfering transactivation properties that can result in distinct
exert autocrine or paracrine functions.cell-specific patterns of gene expression and regulation.
Because the MR has a similarly high affinity for naturalThe second topic is “aldosterone action in epithelia:
glucocorticoids than for the much less abundant mineral-regulated gene products.” In an introductory lecture,
ocorticoid aldosterone, the question of “mineralocorti-Haim Garty briefly traced the history of the research on
coid selectivity,” that is, the role of 11b-HSD2 and otherthis central question. He recalled that more than two
mechanisms, is very important. In classical aldosteronedecades ago Isidore Edelman and colleagues started to
target epithelia, it appears that aldosterone selectivitysearch for so-called “aldosterone-induced” proteins as
is conferred to a large extent by the 11b-HSD2 thatthe mediators of the physiological action, namely the acti-
metabolizes the glucocorticoids and thus functions as avation of Na1 reabsorption across tight epithelia. Until
prereceptor barrier. However, selectivity also appears tovery recently, only a few proteins, which all belong to
be conferred to the action of aldosterone at many otherthe cellular transport machinery, have been identified as
levels, particularly in cells expressing lower levels or noaldosterone-regulated. However, due to the slow time
11b-HSD2.course of their induction, it was clear that they do not
In addition, aldosterone acts in certain cells indepen-account for the early, transcription-mediated, effects of
dent of transcription, possibly via a membrane receptor.aldosterone in target epithelia. Now, increasingly power-
Although some of the data on such actions are still con-ful methods are becoming available to identify differen-
troversial, it was very interesting to discuss these “non-tially expressed mRNAs. Studies are presented that aim
genomic effects of aldosterone” during the meeting. Inat isolating gene products rapidly regulated by aldosterone
a related lecture, F. Barrantes showed that steroids canin target epithelia. As yet two early aldosterone-induced
also directly act on membrane lipids, modulating the
regulatory proteins have been identified that appear to function of membrane proteins, a possibility that has to
affect the function of ENaC, based on coexpression exper- be kept in mind when analyzing the effect of a steroid
iments in Xenopus oocytes: the small G-protein K-Ras2 hormone.
and the protein kinase SGK. The last section is dedicated to “genetics, pathophysi-
“Transgenic animal models,” in which specific gene ology and phamacological aspects.” A detailed pheno-
products are modified or knocked out, are important typic and genotypic analysis of the role of the renin-
new tools to address questions of physiological relevance angiotensin-aldosterone system and Na1 transport in hy-
in vivo. Different models of gene targeting are presented, pertension is provided. Another important point is the
including animals overexpressing the MR and knockout emerging new role of MR antagonists in the treatment
animals for the MR, the ENaC subunits, and the 11b- of cardiac diseases in relation to the cardiac production
HSD2. In addition, new cellular models, in particular and action of aldosterone mentioned above. Glucocorti-
those used to study the regulation of transepithelial Na1 coid hormones and feto-placental 11b-HSD2 have been
transport, are also discussed. shown to be deeply involved in the programming of
Under the title “mechanism of transport activation” blood pressure levels in adulthood. Finally, a concluding
lecture by B. Rossier reviewed the links between bloodby aldosterone or glucocorticoids, detailed studies on
pressure and the mechanisms controlling sodium intakethe effect of these hormones on sodium or potassium
and excretion, and opened stimulatory questions on ge-transport in epithelia are presented. The current goal is
netic as well as non-genetic risk factors.to continue to fill the gap that lies between the gene
In conclusion, we look back to a vigorous Forefrontsregulation by aldosterone (see the aldosterone-induced/
in Nephrology meeting during which many contacts wererepressed proteins mentioned above) and the subse-
established between researchers working on the spec-quent ion transport regulation at the level of the ef-
trum of aldosterone action, all the way from the receptorfectors.
structure to genetically determined defects of the aldo-It has become increasingly evident that aldosterone
sterone-controlled pathways that lead to alterations ofhas many more target cells than originally thought. “Al-
sodium balance and blood pressure.dosterone action in non-epithelial cells” has been dem-
onstrated and detailed for example, in the central ner- Nicolette Farman and Franc¸ois Verrey
Guest Editorsvous and cardiovascular systems. In this respect, it is
